Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20
  • There is currently no data for OSI

Trading Update

14 Jan 2022 07:01

RNS Number : 4163Y
Osirium Technologies PLC
14 January 2022
Β 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.

Β 

14 January 2022

Β 

Osirium Technolgies plc

("Osirium" or the "Group")

Β 

Trading Update

Β 

Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity software, today provides an update on the trading for the financial year ended 31 December 2021 ahead of its audited final results.

Β 

Trading update

Β 

Further to the Company's announcement on 29 November 2021, the Board confirms that, subject to completion of the audit, it expects to report bookings and revenue for the 12 months to 31 December 2021 of at least Β£1.6 million (2020: Β£1.57 million) and Β£1.45 million (2020: Β£1.43 million) respectively, in line with the prior year. Deferred revenue at 31 December 2021 was Β£1.66 million, providing visibility as the Group starts the new year. Debtors and cash balances as at 31 December 2021 were Β£0.7 million.

Β 

Osirium has more than doubled its customer base in 2021 to over 100 customers at 31 December 2021. New customers signed in Q4 2021 included two more NHS trusts, an international telecoms operator and a London-based law firm. Customer retention rates for the year were 95.4% by value (2020: 98.5% retention rate).

Β 

The Group sold through 28 resellers in 2021, and Osirium's increasing emphasis on its reseller and distributor model means it achieved a number of sales in new territories across Western Europe, Central and Eastern Europe, and South Africa.

Β 

Whilst average initial contract values have been lower due to the delayed decision making on larger strategic IT projects throughout the pandemic, the Group's significantly increased customer base provides increased up-sell opportunities, in line with its land and expand strategy. The Group expects to build on existing contracts and expand its services with its new customers in 2022 alongside accelerating new customer acquisition. Osirium starts the new year with c. Β£1.5 million of anticipated bookings from existing customer renewals due in 2022, which, coupled with the Company's track record of high customer retention, provides a strong foundation for the Group to execute its growth strategy.

Β 

Β 

David Guyatt, CEO of Osirium, commented:

Β 

"We are pleased with the strong growth in customer numbers and high customer retention rates during 2021, which is testament to the need for our offering across a range of sectors and geographies despite the effects of the pandemic upon customer decision making. We expect this customer decision making to return towards normal levels in 2022.

Β 

"With a significantly broadened customer base, our teams have the opportunity to focus on upselling and cross-selling in line with our land-and-expand strategy. We have made good progress in the year following a focus on growing our partner network which is yielding results, and we continue to assess the Company's go-to-market strategies to ensure the Group remains well-positioned to capture the substantial market opportunity available. I look forward to providing a full update to shareholders at the final results later in the year."

Β 

Contacts:

Β 

Β 

Β 

Osirium Technologies plc

Tel: +44 (0)1183 242 444

David Guyatt, CEO

Β 

Rupert Hutton, CFO

Β 

Β 

Β 

Allenby Capital Limited (Nominated adviser and broker)

Tel: +44 (0)20 3328 5656

James Reeve/George Payne (Corporate Finance)

Β 

Tony Quirke (Sales and Corporate Broking)

Β 

Β 

Β 

Alma PR (Financial PR adviser)

Tel: +44 (0)20 3405 0205

Hilary Buchanan

osirium@almapr.co.uk

Kieran Breheny

Β 

Faye Calow

Β 

Β 

About Osirium TechnologiesΒ Plc

Β 

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain.Β 

Β 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

Β 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFXLLFLFLBBBL
Date   Source Headline
1st Nov 202211:00 amRNSPrice Monitoring Extension
1st Nov 20227:00 amRNSQ3 2022 trading update
23rd Sep 202211:06 amRNSSecond Price Monitoring Extn
23rd Sep 202211:00 amRNSPrice Monitoring Extension
22nd Sep 20222:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20222:00 pmRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results
20th Sep 20227:00 amRNSSignificant contract extension
12th Sep 20227:00 amRNSNotice of Results
3rd Aug 20227:00 amRNSSignificant contract extension
21st Jul 20227:00 amRNSContract Win
8th Jul 20227:00 amRNSTrading Update
8th Jun 20224:40 pmRNSSecond Price Monitoring Extn
8th Jun 20224:35 pmRNSPrice Monitoring Extension
7th Jun 20221:02 pmRNSResult of AGM
30th May 20227:00 amRNSContract win for PEM solution
17th May 20227:00 amRNSFirst contract win in the United States
11th May 20227:00 amRNSReport and Accounts and Notice of AGM
5th May 20224:41 pmRNSSecond Price Monitoring Extn
5th May 20224:36 pmRNSPrice Monitoring Extension
27th Apr 20224:41 pmRNSSecond Price Monitoring Extn
27th Apr 20224:36 pmRNSPrice Monitoring Extension
25th Apr 20224:41 pmRNSSecond Price Monitoring Extn
25th Apr 20224:35 pmRNSPrice Monitoring Extension
21st Apr 202211:05 amRNSSecond Price Monitoring Extn
21st Apr 202211:00 amRNSPrice Monitoring Extension
21st Apr 20227:00 amRNSFinal Results
8th Apr 20222:06 pmRNSSecond Price Monitoring Extn
8th Apr 20222:00 pmRNSPrice Monitoring Extension
7th Apr 20222:05 pmRNSSecond Price Monitoring Extn
7th Apr 20222:00 pmRNSPrice Monitoring Extension
7th Apr 20229:00 amRNSPrice Monitoring Extension
6th Apr 20222:06 pmRNSSecond Price Monitoring Extn
6th Apr 20222:01 pmRNSPrice Monitoring Extension
6th Apr 202211:05 amRNSSecond Price Monitoring Extn
6th Apr 202211:00 amRNSPrice Monitoring Extension
5th Apr 20224:41 pmRNSSecond Price Monitoring Extn
5th Apr 20224:36 pmRNSPrice Monitoring Extension
5th Apr 20222:06 pmRNSSecond Price Monitoring Extn
5th Apr 20222:00 pmRNSPrice Monitoring Extension
5th Apr 202211:05 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
5th Apr 20227:00 amRNSQ1 2022 Trading Update
1st Apr 20224:57 pmRNSHolding(s) in Company
31st Mar 20225:00 pmRNSTotal Voting Rights
25th Mar 20222:05 pmRNSSecond Price Monitoring Extn
25th Mar 20222:00 pmRNSPrice Monitoring Extension
24th Mar 20222:05 pmRNSSecond Price Monitoring Extn
24th Mar 20222:00 pmRNSPrice Monitoring Extension
24th Mar 20227:00 amRNSContract win for Privileged Process Automation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.